![]() ![]() | Van de Velde, M., Ebroin, M., Durré, T., Joiret, M., Gillot, L., Blacher, S., Geris, L., Kridelka, F., & Noël, A. (2021). Tumor exposed-lymphatic endothelial cells promote primary tumor growth via IL6. Cancer Letters, 497, 154-164. doi:10.1016/j.canlet.2020.10.020 ![]() |
![]() ![]() | Eldafrawy, M., Ebroin, M., Gailly, P., Nguyen, J.-F., Sadoun, M., & Mainjot, A. (2018). Bonding to CAD-CAM Composites: An Interfacial Fracture Toughness Approach. Journal of Dental Research. doi:10.1177/0022034517728714 ![]() |
![]() ![]() | Durré, T., Morfoisse, F., ERPICUM, C., Ebroin, M., Blacher, S., García Caballero, M., Deroanne, C., Louis, T., BALSAT, C., Van De Velde, M., Kaijalainen, S., Kridelka, F., Engelholm, L., Struman, I., Alitalo, K., Behrendt, N., Paupert, J., & Noël, A. (2018). uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis. Nature Communications, 9 (1), 5178. doi:10.1038/s41467-018-07514-1 ![]() |
Morfoisse, F., Durré, T., ERPICUM, C., Ebroin, M., Blacher, S., Garcia-caballero, M., Deroanne, C., Behrendt, N., Paupert, J., & Noël, A. (08 June 2017). uPARAP/endo180 receptor acts as a gatekeeper of pathological lymphangiogenesis by controlling VEGF-C driven lymphatic endothelial cell migration [Poster presentation]. Lymphatic Forum 2017, Chicago, United States - Illinois. |
![]() ![]() | Eldafrawy, M., Ebroin, M., Gailly, P., Nguyen, J.-F., Sadoun, M., & Mainjot, A. (2017). PICN Versus Dispersed Filler Materials Interfacial KIC With Resin Cement. Journal of Dental Research. ![]() |
Ebroin, M. (2016). Bonding properties of innovative CAD-CAM composite biomaterials for dental prostheses [Master’s dissertation, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/219890 |